Cargando…
Report of the EORTC-PAMM Meeting, Brussels, 16–18 March 2009: new strategies for a targeted and personalised therapy of cancer
Autor principal: | Camporesi, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224003/ https://www.ncbi.nlm.nih.gov/pubmed/22276006 http://dx.doi.org/10.3332/ecancer.2009.141 |
Ejemplares similares
-
Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
por: Ciccolini, Joseph, et al.
Publicado: (2016) -
Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.
por: McLeod, H. L., et al.
Publicado: (1996) -
Phase 0 Workshop at the 20th EORTC-NCI-AACR Symposium, Geneva
por: Camporesi, S
Publicado: (2008) -
Conference report on the 14th International Society of Paediatric Oncology African Continental Meeting, 16–18 March 2022, Kampala, Uganda
por: van Heerden, Jaques, et al.
Publicado: (2022) -
PAMM and the ischemic cascade associated with radiation retinopathy
por: Wang, Derrick, et al.
Publicado: (2020)